Alira Health's Transformation Talks
By Alira Health
Alira Health's Transformation TalksJul 20, 2022
The Promise and Reality of Next Generation Therapies
Our Transformation Talks Summer Special is here!
Tune in to learn about risks and challenges in developing a Next-Generation Therapy (NGT), bringing it to the market, and how NGTs can change patients’ lives once their value is understood and correctly attributed by the decision makers / payers.
Meet our speakers:
- Andrea Mantovani – Vice President, Global Market Access and Pricing, Alira Health
- Oswald Bentinck - Vice President - Head of Market Access EMEA, Novartis Gene Therapies
- Pietro Sternini - Executive Director, Gene Therapy Market Access & Marketing Lead, EMEA, Astellas Gene Therapies
Meet our host:
Kenny Carberry – Director, Clinical Development, Alira Health
This episode is also available in video format, check it out on our YouTube channel: https://youtu.be/u-ThcNNc7Uk
Download this episode's handouts here.
The IVDR Is Here: What You Need to Know
The In-Vitro Diagnostic Regulation (IVDR) is now here! What does it mean for the industry? How can companies ensure compliance after the 26th of May? In this episode of Transformation Talks, our in-house expert Ainoa Forteza, Associate Director of Regulatory Affairs, will discuss these and many other questions with Kenny Carberry, host of Transformation Talks and Director of Clinical Development at Alira Health.
Meet our speakers:
Ainoa Forteza - Associate Director of Regulatory Affairs, Alira Health
Ainoa Forteza is a Regulatory expert on Medical Devices and In Vitro Diagnostics. She helps companies develop their MedTech products according to the applicable regulatory requirements, with a special mention to MDR and IVDR. With 7+ years of experience in industry, Ainoa’s previous roles include positions at consulting firm (DDR, currently Veristat) where she was in charge of the team responsible for Medical Devices and In Vitro Diagnostics.
Meet our host:
Kenny Carberry – Director, Clinical Development, Alira Health
Kenny leads business development efforts and initiatives for early-stage healthcare companies. His background covers various indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle, from generating a comprehensive strategy to executing a successful trial.
Real-World Data to Support HTAs in Europe
In this new episode titled "Real-World Data to Support HTAs in Europe", we will examine the various uses of Real-World Data (RWD) and how it is valued in Health Technology Assessments in multiple European nations. Learn more about using RWD as support in HTAs and its direct impact on HTAs budgets, results, and even patient outcomes by listening to this episode of Transformation Talks.
Meet our guests:
Catia Proenca – Director, Clinical Real-World Evidence, Alira Health
Catia designs and manages Real-World Evidence strategies maintaining a Market Access perspective by ensuring key stakeholder needs (e.g., HTA, payers) are met, thus, maximizing access to innovation, and ultimately improving patient outcomes. With 13+ years of experience in industry and academia, Catia’s previous roles include positions at Wellmera, Novartis Global, and the Novartis Institute for Biomedical Research. Catia holds a PhD in Neuroscience from the Weill Cornell Medical College, New York, and the University of Lisbon.
Carsten Schwenke – HTA Expert
Carsten Schwenke is a licensed biostatistician and health economist, with a PhD in public health, that has 25 years of experience in the pharmaceutical sector, focusing on clinical development and market access. He has been self-employed for the past 15 years, with a primary focus on the German HTA process.
Meet our host:
Kenny Carberry – Director, Clinical Development, Alira Health
Kenny leads business development efforts and initiatives for early-stage healthcare companies. His background covers various indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle, from generating a comprehensive strategy to executing a successful trial.
Real-World Evidence Strategy Playbook
Medical and healthcare data have been gathered through various channels over the last twenty years, and with recent innovations, it offers new opportunities, becoming a crucial factor in market access strategies and clinical research. In this episode of Alira Health's Transformation Talks, our host Kenny Carberry, Director of Clinical Development at Alira Health, and Romain Finas, Vice President of Real-World Evidence at Alira Health, will discuss how industry stakeholders can leverage RWD to be more efficient, cost-effective, and thus increase their benefits without compromising quality.
Listen to this podcast to discover how industry stakeholders may use RWD to be more efficient, cost-effective, and maximize their benefits without sacrificing data quality and why the role of patients as an essential aspect of data gathering and sourcing cannot be overlooked when considering RWE.
Meet our speakers:
Romain Finas - Vice President, Real-World Evidence, Alira Health
Romain Finas has been building the Real-World Evidence practice for AliraHealth since mid-2020. Before AliraHealth, Romain designed and implemented the“beyond the pill” strategy for MSD France. He started living labs to test and assess innovations based on real-time data routinely collected by practitioners, among other initiatives. Romain has 20 years of experience in consultancy, healthcare, and digital.
Meet our host:
Kenny Carberry - Director, Clinical Development, Alira Health
Kenny leads business development efforts and initiatives for early-stage healthcare companies. His background covers various indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle, from generating a comprehensive strategy to executing a successful trial.
An Advanced Perspective on Advanced Diagnostics: A Roadmap to the Future of Genomics
The advanced diagnostic ecosystem and genetic data have the power to transform healthcare systems, improve patient outcomes, and revolutionize the efficiency of care delivery.
Learn more about the impact of advanced diagnostics on healthcare systems globally. Our 'Transformation Talks’ podcast, will feature guests from Illumina, one of the leading companies in next-generation sequencing (NGS), who will discuss NGS technology, how patients benefit globally from groundbreaking sequencing techniques, and what are the key barriers to adoption of genomics in patient care, and the importance of both education and real-world evidence (RWE):
- Brock Schroeder, Senior Director, Global Market Access Strategy & HEOR, Illumina
- Véronique Forest, Senior Director, Field Market Access for Europe, Middle East & Africa, Illumina
The discussion will also feature Alira Health’s Richard Charter, Vice President MedTech Market Access Europe & Asia Pacific, who will discuss a multistakeholder perspective on the challenges in moving NGS into clinical practice. Hosted by our very own Kenny Carberry, Associate Director of Clinical Development at Alira Health.
Join us to dive into the future challenges to the holistic implementation of Genomics in clinical practice and how NGS can transform healthcare and improve the lives of patients. Tune in!
Early Access Programs: Why and How?
Early Access Programs (EAPs) offer the healthcare industry enormous advantages - not only do they allow patients with a high unmet medical need access to the innovative medicines prior to their commercialization, but they also allow pharmaceutical companies to generate KOL engagement, enabling them to accelerate reimbursement while leveraging evidence to support P&R and market access.
However, despite all significant benefits, EAPs still remain a black box for the industry due to their complexity.
Listen to this episode of "Transformation Talks" to discover the benefits and challenges of implementing EAPs from both the industry and payer perspectives, and the main recommendations for their effective design and implementation in Europe. This episode's guests include Lois Beecroft, Global Pricing and Market Access Director at GSK, and Jacqui Lyttle, Senior Independent Director at NHS Foundation Trust in Torbay and South Devon, our host Kenny Carberry, Associate Director of Clinical Development at Alira Health, and our co-host Nerea Blanqué-Catalina, VP of Global Market Access & Pricing at Alira Health.
Would you like to understand the complexity of launching EAPs, discover their benefits and learn about the related challenges and ways to overcome them? Download our white paper here.
Navigating the Vaccines Renaissance
The pandemic has revived interest in vaccines, but will this renaissance last forever?
Tune into this episode of "Transformation Talks" to learn more about the past, present, and future of the vaccine industry, from the lack of innovation for the last 20 years to new technologies like mRNA platforms and whole-cell vaccines. Alira Health's expert in vaccines Bernd Schollmeier, VP of Global Market Access – Vaccines, and our host Kenny Carberry, Associate Director of Clinical Development at Alira Health, will discuss the ups and downs of the vaccine industry, how the COVID pandemic has transformed it, and what is impending.
Are you interested in discovering the world of vaccines? Follow us on LinkedIn to be the first one to sign up for the exclusive series of appointments with vaccine experts!
Overcoming Challenges to Reimbursement in Robotic Surgery for the French Market
Our latest Alira Health Transformation Talks is all about Robotic Surgery.
In this month’s episode, Pr. Jacques Hubert, Head of the Urology Department at Nancy University Hospital (France), Christophe Michel, Associate Director, Medical Device & Connected Health at Alira Health, and our host Kenny Carberry, Associate Director of Clinical Development at Alira Health, talk about their experience in overcoming challenges, managing risk, and obtaining reimbursement in Robotic Surgery for the French Market through different initiatives.
To learn more about our MedTech Market Access services click here.
Creating a lifecycle of Patient Engagement
On the latest episode of Alira Health’s Transformation Talks Podcast, our guests Raj Kannan, CEO & President, Chiasma, Inc., Annabel de Maria, VP Patient Engagement at Alira Health, and our host Kenny Carberry, Associate Director of Clinical Development at Alira Health, meet to discuss the opportunities that healthcare companies have to engage with patients at each stage of the life cycle management.
Making the patient‘s voice heard throughout this process will not only improve patient outcomes and experiences but will help the company achieve its business goals.
To learn more about this topic you can download our brochure by clicking here.
Managing Relationships Between CROs and Clinical Trial Sites
Join us in this special episode of Alira Health’s Transformation Talks with a full cast of Alira Health experts.
In today’s episode our host Kenny Carberry, Associate Director of Clinical Development, and our guests Christopher Rao, Vice President, Peggy Healy, Project Manager, and Kristóf Vajda, Associate Project Manager, explore different challenges and perspectives around building, managing, and maintaining relationships between Clinical CROs and trial site research staff.
Learn more about our Clinical services by clicking here.
Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes
The Drug Delivery Systems (DDS) industry has gone through extensive changes in the last few decades due to its increasing role in driving patient care and outcomes. It has pushed players to develop new strategies that cover the dynamic needs of their biopharmaceutical customers.
Join our guest Amira Ghozali, Director, Strategy and Market Intelligence, Aptar Pharma, Aude Ouensanga, Partner at Alira Health, and our host Kenny Carberry, Associate Director of Clinical Development, Alira Health as they discuss the impact of COVID-19, the evolution of the industry and its future, and of the relationship between DDS organizations and the Pharma industry by sharing insights and experiences from the perspective of a multinational healthcare consulting firm and a global manufacturer and supplier of consumer dispensing packaging and drug delivery services.
For recent insights on the Drug Delivery Devices industry, download our latest report here.
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
The second episode of Alira Health’s Transformation Talks is out, and this month we’re discussing pricing in MedTech amid recent changes to NHS organization and funding.
Join our host Kenny Carberry, Associate Director of Clinical Development at Alira Health, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO and Founder of Quantmed UK, and Richard Charter, Alira Health's VP of MedTech Market Access in Europe & Asia-Pacific, as they discuss the latest changes in pricing in MedTech by disentangling the roles of payers, DRGs, and procurement against the backdrop of recent NHS reforms.
Latest News on the WHO Guideline
Tune in for our first episode on the recently updated WHO Guideline with our insight industry experts calling from around the globe, Omar Ali, Lecturer Value-Based Pricing & Outcomes Based Innovative Contracting & Former Member Adoption & Impact Panel at NICE, and Oscar Pérez Albet, Chief Business Development & Global Alliances Officer, and our Alira Health hosts Kenny Carberry, Associate Director of Clinical Development, and Nerea Blanqué-Catalina, VP of Market Access & Pricing.
To get a copy of Alira Health’s exclusive report click here and if you want learn more contact Nerea Blanqué-Catalina by email: nerea.blanque@alirahealth.com